- Home
- KTTA vs CNF Comparison
KTTA vs CNF Comparison
Compare KTTA & CNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- CNF
- Stock Information
- Founded
- KTTA 2020
- CNF 1999
- Country
- KTTA United States
- CNF China
- Employees
- KTTA N/A
- CNF N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- CNF Finance: Consumer Services
- Sector
- KTTA Health Care
- CNF Finance
- Exchange
- KTTA Nasdaq
- CNF Nasdaq
- Market Cap
- KTTA 5.5M
- CNF 35.7M
- IPO Year
- KTTA 2021
- CNF 2018
- Fundamental
- Price
- KTTA $0.68
- CNF $0.78
- Analyst Decision
- KTTA
- CNF
- Analyst Count
- KTTA 0
- CNF 0
- Target Price
- KTTA N/A
- CNF N/A
- AVG Volume (30 Days)
- KTTA 142.8K
- CNF 149.8K
- Earning Date
- KTTA 08-12-2025
- CNF 08-27-2025
- Dividend Yield
- KTTA N/A
- CNF N/A
- EPS Growth
- KTTA N/A
- CNF N/A
- EPS
- KTTA N/A
- CNF 0.08
- Revenue
- KTTA N/A
- CNF $85,661,735.00
- Revenue This Year
- KTTA N/A
- CNF $252.34
- Revenue Next Year
- KTTA N/A
- CNF N/A
- P/E Ratio
- KTTA N/A
- CNF $10.60
- Revenue Growth
- KTTA N/A
- CNF N/A
- 52 Week Low
- KTTA $0.67
- CNF $0.37
- 52 Week High
- KTTA $7.50
- CNF $2.84
- Technical
- Relative Strength Index (RSI)
- KTTA 32.67
- CNF 66.16
- Support Level
- KTTA $0.67
- CNF $0.60
- Resistance Level
- KTTA $0.77
- CNF $0.83
- Average True Range (ATR)
- KTTA 0.04
- CNF 0.10
- MACD
- KTTA 0.01
- CNF 0.02
- Stochastic Oscillator
- KTTA 14.02
- CNF 90.38
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
About CNF CNFinance Holdings Limited each representing twenty (20)
CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, it has an operation in PRC.